Taiwan Bio Therapeutics Co., Ltd
TWO: 6892.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Chun Yao Yang
- Headquarters
- Taipei City, Taiwan
- IPO year
- 2022
- Market cap
- NT$2.4B
- Website
- https://www.twbio-thera.com
Loading 6892…
Loading profile data…Frequently asked questions about 6892
What does Taiwan Bio Therapeutics Co., Ltd (6892.TWO) do?
Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei City, Taiwan.
Where does 6892.TWO trade?
Taiwan Bio Therapeutics Co., Ltd (6892.TWO) trades on the Taipei Exchange.
What sector is 6892.TWO in?
Taiwan Bio Therapeutics Co., Ltd (6892.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Taiwan Bio Therapeutics Co., Ltd?
Chun Yao Yang is the chief executive officer of Taiwan Bio Therapeutics Co., Ltd (6892.TWO).
Where is Taiwan Bio Therapeutics Co., Ltd headquartered?
Taiwan Bio Therapeutics Co., Ltd is headquartered in Taiwan.
Does 6892.TWO pay a dividend?
Taiwan Bio Therapeutics Co., Ltd (6892.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6892.TWO go public?
Taiwan Bio Therapeutics Co., Ltd (6892.TWO) completed its initial public offering in 2022.